Coloplast AS (OCSE:COLO B) 3-Year EBITDA Growth Rate : 4.50% (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS 3-Year EBITDA Growth Rate?

Coloplast AS's EBITDA per Share for the three months ended in Mar. 2025 was kr9.54.

During the past 12 months, Coloplast AS's average EBITDA Per Share Growth Rate was 5.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 4.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Coloplast AS was 48.30% per year. The lowest was -21.20% per year. And the median was 7.95% per year.

Competitive Comparison of Coloplast AS's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Coloplast AS's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Coloplast AS's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Coloplast AS 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Coloplast AS (OCSE:COLO B) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Coloplast AS 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Coloplast AS's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA 0QBO:Mexico COLOBc:UK 0QBO:UK CBHD:Germany COLO:Austria

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines